Troponin T: a diagnostic marker for myocardial infarction and minor cardiac cell damage
W Rottbauer1, T Greten, M Müller-Bardorff
1University Hospital, Department of Internal Medicine III, Heidelberg, Germany.
Insights
A rapid troponin T test aids in diagnosing myocardial infarction and identifying high-risk patients with unstable angina. This bedside test improves chest pain patient triage and treatment selection.
Area of Science:
- Cardiology
- Biochemistry
- Emergency Medicine
Background:
- Diagnosis of acute myocardial infarction (MI) is clear with typical ECG changes, negating routine cardiac marker use.
- Cardiac markers can identify high-risk subgroups in acute ischemic coronary syndromes, even with minor myocardial damage.
- Biochemical assays are crucial for diagnosing myocardial cell injury in many chest pain patients.
Purpose of the Study:
- To evaluate the utility of a rapid troponin T test for diagnosing myocardial injury.
- To assess the impact of rapid troponin T testing on the management of chest pain patients.
- To determine if elevated troponin T in unstable angina indicates a prognosis similar to definite MI.
Main Methods:
- Utilized a rapid troponin T test strip assay for whole blood analysis at the bedside.
- Compared troponin T levels with ECG and cardiac enzyme results in chest pain patients.
- Followed patient outcomes at 4 weeks and 6 months.
Main Results:
- Elevated troponin T was observed in 30% of unstable angina patients initially ruled out for MI by ECG and cardiac enzymes.
- These patients with elevated troponin T showed similar outcomes to those with definite MI at follow-up.
- The rapid troponin T assay provides timely results suitable for emergency room or basic laboratory settings.
Conclusions:
- Rapid troponin T testing is valuable for diagnosing myocardial injury and identifying high-risk unstable angina patients.
- The bedside assay facilitates rapid triage and therapeutic decision-making for chest pain patients.
- Timely troponin T results can significantly impact patient management and potentially improve outcomes.
Abstract:
The diagnosis of acute myocardial infarction is straightforward when anginal pain is accompanied by typical ECG changes and in these patients measurements of cardiac markers are unnecessary in deciding whether thrombolytic therapy is appropriate. Cardiac markers in patients with acute ischaemic coronary syndromes, however, may serve to identify a high risk subgroup of patients with small acute infarctions or minor myocardial damage. In many patients with chest pain a valid diagnosis of myocardial cell injury depends on the result of biochemical assays. In 30% of patients with unstable angina, troponin T is elevated although myocardial infarction was ruled out by cardiac enzymes and ECG recordings. The outcome of these patients at 4 weeks and 6 months follow-up is not different from that of patients with definite myocardial infarction. To guide therapeutic decisions on these patients a troponin T test result needs to be available rapidly. The rapid troponin T test strip assay, which allows the determination of troponin T levels in whole blood at the patient's bedside, can be performed conveniently in the emergency room or in laboratories with less sophisticated equipment and has the potential to aid in the triage of chest pain patients and the selection of therapeutic strategies.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:21Myocarditis I: Introduction
01:27Myocarditis II: Clinical Features and Diagnostic Tests
01:30Acute Coronary Syndrome I: Introduction
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:26Transient Ischemic Attack l: Introduction